Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HOMER3 antisense RNA 1 (HOMER3-AS1) is a long non-coding RNA transcribed antisense to the HOMER3 gene. It is overexpressed in hepatocellular carcinoma and correlated with poor patient survival. Functional studies indicate that HOMER3-AS1 promotes tumor cell proliferation, migration, and invasion, inhibits apoptosis, and facilitates recruitment and M2-like polarization of macrophages in the tumor microenvironment, primarily by upregulating HOMER3 and activating Wnt/β-catenin signaling, as well as increasing the expression and secretion of CSF-1. HOMER3-AS1 is under investigation as a potential prognostic biomarker and a promising therapeutic target in liver cancer settings[2][4].
Modulation of HOMER3 expression and subsequent activation of Wnt/β-catenin signaling; Upregulation of colony stimulating factor 1 (CSF-1) to promote macrophage recruitment and M2 polarization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HOMER3 antisense RNA 1 (HOMER3-AS1).